Works by Nauck, Michael

Results: 165

Comparative efficacy and tolerability of currently approved incretin mimetics: A systematic analysis of placebo‐controlled clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 3736, doi. 10.1111/dom.16398

By:

Kang, Yu Mi;
Punov, Viktoria;
Lim, Soo;
Nauck, Michael A.

Publication type:

Article

Randomised comparison of intravenous and subcutaneous routes of glucagon‐like peptide‐1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3897, doi. 10.1111/dom.15736

By:

Quast, Daniel R.;
Lancaster, Dara;
Xie, Cong;
Bound, Michelle J.;
Grivell, Jacqueline;
Jones, Karen L.;
Horowitz, Michael;
Meier, Juris J.;
Wu, Tongzhi;
Rayner, Christopher K.;
Nauck, Michael A.

Publication type:

Article

Getting the measure of the pressure: Optimal assessment of the effects of glucagon‐like peptide‐1 receptor agonists on blood pressure.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3003, doi. 10.1111/dom.15631

By:

Jones, Karen L.;
Marathe, Chinmay S.;
Wu, Tongzhi;
Rayner, Christopher K.;
Nauck, Michael;
Horowitz, Michael

Publication type:

Article

Meta‐analysis of head‐to‐head clinical trials comparing incretin‐based glucose‐lowering medications and basal insulin: An update including recently developed glucagon‐like peptide‐1 (GLP‐1) receptor agonists and the glucose‐dependent insulinotropic polypeptide/GLP‐1 receptor co‐agonist tirzepatide

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1361, doi. 10.1111/dom.14988

By:

Nauck, Michael A.;
Mirna, Abd El Aziz;
Quast, Daniel R.

Publication type:

Article

Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 806, doi. 10.1111/dom.14636

By:

Meier, Juris J.;
Quast, Daniel R.;
Nauck, Michael A.;
Schenker, Nina;
Deacon, Carolyn F.;
Holst, Jens J.;
Plum‐Mörschel, Leona;
Kapitza, Christoph

Publication type:

Article

Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting glucagon‐like peptide‐1 receptor agonists in type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2344, doi. 10.1111/dom.14477

By:

Quast, Daniel R.;
Nauck, Michael A.;
Schenker, Nina;
Menge, Björn A.;
Kapitza, Christoph;
Meier, Juris J.

Publication type:

Article

The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, p. 5, doi. 10.1111/dom.14496

By:

Nauck, Michael A.;
Quast, Daniel R.;
Wefers, Jakob;
Pfeiffer, Andreas F. H.

Publication type:

Article

The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, p. 5, doi. 10.1111/dom.14496

By:

Nauck, Michael A.;
Quast, Daniel R.;
Wefers, Jakob;
Pfeiffer, Andreas F. H.

Publication type:

Article

Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2193, doi. 10.1111/dom.14140

By:

Verma, Subodh;
Bain, Stephen C.;
Honoré, Julie Broe;
Mann, Johannes F. E.;
Nauck, Michael A.;
Pratley, Richard E.;
Rasmussen, Søren;
Ripa, Maria Sejersten;
Zinman, Bernard;
Buse, John B.

Publication type:

Article

The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 (GLP‐1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long‐acting GLP‐1 receptor agonists

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1886, doi. 10.1111/dom.14110

By:

Urva, Shweta;
Coskun, Tamer;
Loghin, Corina;
Cui, Xuewei;
Beebe, Emily;
O'Farrell, Libbey;
Briere, Daniel A.;
Benson, Charles;
Nauck, Michael A.;
Haupt, Axel

Publication type:

Article

Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN‐6 cardiovascular outcomes trials.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1537, doi. 10.1111/dom.14063

By:

Kahkoska, Anna R.;
Geybels, Milan S.;
Klein, Klara R.;
Kreiner, Frederik F.;
Marx, Nikolaus;
Nauck, Michael A.;
Pratley, Richard E.;
Wolthers, Benjamin O.;
Buse, John B.

Publication type:

Article

Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimens

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 6, p. 938, doi. 10.1111/dom.13979

By:

Frias, Juan Pablo;
Nauck, Michael A.;
Van, Joanna;
Benson, Charles;
Bray, Ross;
Cui, Xuewei;
Milicevic, Zvonko;
Urva, Shweta;
Haupt, Axel;
Robins, Deborah A.

Publication type:

Article

Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal‐related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 599, doi. 10.1111/dom.13935

By:

Meier, Juris J.;
Menge, Björn A.;
Schenker, Nina;
Erdmann, Silke;
Kahle‐Stephan, Melanie;
Schliess, Freimut;
Kapitza, Christoph;
Nauck, Michael A.

Publication type:

Article

Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and malignancies: a meta‐analysis based on cardiovascular outcomes trials.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 699, doi. 10.1111/dom.13924

By:

Abd El Aziz, Mirna;
Cahyadi, Oscar;
Meier, Juris J.;
Schmidt, Wolfgang E.;
Nauck, Michael A.

Publication type:

Article

Long‐term efficacy and safety of combined insulin and glucagon‐like peptide‐1 therapy: Evidence from the LEADER trial.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2450, doi. 10.1111/dom.13826

By:

Tack, Cees J.;
Jacob, Stephan;
Desouza, Cyrus;
Bain, Stephen C.;
Buse, John B.;
Nauck, Michael A.;
Petrie, John R.;
Poulter, Neil R.;
Pratley, Richard E.;
Stegmann, Helen Vanya B. K.;
Bosch‐Traberg, Heidrun;
Startseva, Elena;
Zinman, Bernard

Publication type:

Article

Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1745, doi. 10.1111/dom.13698

By:

Verma, Subodh;
Mazer, C. David;
Bain, Stephen C.;
Monk Fries, Tea;
Rasmussen, Søren;
Saevereid, Hans A.;
Nauck, Michael A.;
Pratley, Richard E.;
Zinman, Bernard;
Buse, John B.

Publication type:

Article

Health‐related quality of life in people with type 2 diabetes participating in the LEADER trial.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 525, doi. 10.1111/dom.13547

By:

Nauck, Michael A.;
Buse, John B.;
Mann, Johannes F. E.;
Pocock, Stuart;
Bosch‐Traberg, Heidrun;
Frimer‐Larsen, Helle;
Ye, Qing;
Gray, Alastair

Publication type:

Article

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 499, doi. 10.1111/dom.13553

By:

Bain, Stephen C.;
Mosenzon, Ofri;
Arechavaleta, Rosario;
Bogdański, Pawel;
Comlekci, Abdurrahman;
Consoli, Agostino;
Deerochanawong, Chaicharn;
Dungan, Kathleen;
Faingold, Maria C.;
Farkouh, Michael E.;
Franco, Denise R.;
Gram, Jeppe;
Guja, Cristian;
Joshi, Pankaj;
Malek, Rachid;
Merino‐Torres, Juan F.;
Nauck, Michael A.;
Pedersen, Sue D.;
Sheu, Wayne H. ‐H.;
Silver, Robert J.

Publication type:

Article

Incretin hormones: Their role in health and disease.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, p. 5, doi. 10.1111/dom.13129

By:

Nauck, Michael A.;
Meier, Juris J.

Publication type:

Article

Incretin-based glucose-lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio-vascular outcome trials.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 9, p. 1327, doi. 10.1111/dom.12981

By:

Nauck, Michael A.;
Meier, Juris J.;
Schmidt, Wolfgang E.

Publication type:

Article

Basal rate tests (24-hour fasts) performed in type-1 diabetic subjects with either absolute fasting or snacks containing negligible carbohydrate amounts result in similar glucose profiles: A randomized controlled prospective trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 783, doi. 10.1111/dom.12868

By:

Haase, Maike;
Kahle, Melanie;
Janert, Martin;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

Article

Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 336, doi. 10.1111/dom.12824

By:

Bettge, Karolin;
Kahle, Melanie;
Abd El Aziz, Mirna S.;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

Article

Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 200, doi. 10.1111/dom.12802

By:

Nauck, Michael A.;
Kahle, Melanie;
Baranov, Oleg;
Deacon, Carolyn F.;
Holst, Jens J.

Publication type:

Article

A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 216, doi. 10.1111/dom.12804

By:

Abd El Aziz, Mirna S.;
Kahle, Melanie;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

Article

Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 12, p. 1253, doi. 10.1111/dom.12766

By:

Ueberberg, Sandra;
Jütte, Hendrik;
Uhl, Waldemar;
Schmidt, Wolfgang;
Nauck, Michael;
Montanya, Eduard;
Tannapfel, Andrea;
Meier, Juris

Publication type:

Article

Feedback suppression of meal-induced glucagon-like peptide-1 ( GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 11, p. 1100, doi. 10.1111/dom.12706

By:

Baranov, Oleg;
Kahle, Melanie;
Deacon, Carolyn F.;
Holst, Jens J.;
Nauck, Michael A.

Publication type:

Article

Accurate Measurements of Gastric Emptying and Gastrointestinal Symptoms in the Evaluation of Glucagon-like Peptide-1 Receptor Agonists.

Published in:

Annals of Internal Medicine, 2023, v. 176, n. 11, p. 1542, doi. 10.7326/M23-2019

By:

Jalleh, Ryan J.;
Jones, Karen L.;
Nauck, Michael;
Horowitz, Michael

Publication type:

Article

Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility.

Published in:

Endocrinology, 2025, v. 166, n. 1, p. 1, doi. 10.1210/endocr/bqae155

By:

Jalleh, Ryan J;
Marathe, Chinmay S;
Rayner, Christopher K;
Jones, Karen L;
Umapathysivam, Mahesh M;
Wu, Tongzhi;
Quast, Daniel R;
Plummer, Mark P;
Nauck, Michael A;
Horowitz, Michael

Publication type:

Article

SGLT-2 Inhibition and the Endocrine Pancreatic Alpha Cell: Direct or Indirect Mechanisms of Inhibition?

Published in:

Endocrinology, 2020, v. 161, n. 8, p. 1, doi. 10.1210/endocr/bqaa107

By:

Meier, Juris J;
Nauck, Michael A

Publication type:

Article

Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction.

Published in:

Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01604-7

By:

Nauck, Michael A.;
D'Alessio, David A.

Publication type:

Article

Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.

Published in:

Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01481-0

By:

Schnell, Oliver;
Battelino, Tadej;
Bergenstal, Richard;
Blüher, Matthias;
Böhm, Michael;
Brosius, Frank;
Carr, Richard D.;
Ceriello, Antonio;
Forst, Thomas;
Giorgino, Francesco;
Guerci, Bruno;
Heerspink, Hiddo J. L.;
Itzhak, Baruch;
Ji, Linong;
Kosiborod, Mikhail;
Lalić, Nebojša;
Lehrke, Michael;
Marx, Nikolaus;
Nauck, Michael;
Rodbard, Helena W.

Publication type:

Article

Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 Diabetes.

Published in:

Endocrinology & Metabolism, 2025, v. 40, n. 1, p. 156, doi. 10.3803/EnM.2024.2150

By:

Hun Jee Choe;
Nauck, Michael A.;
Joon Ho Moon

Publication type:

Article

Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective.

Published in:

Diabetes & Metabolism Journal, 2023, v. 47, n. 1, p. 140, doi. 10.4093/dmj.2021.0322

By:

Laspe, Insa;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

Article

Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials.

Published in:

Diabetes & Metabolism Journal, 2019, v. 43, n. 4, p. 410, doi. 10.4093/dmj.2018.0070

By:

Yu Mi Kang;
Yun Kyung Cho;
Jiwoo Lee;
Seung Eun Lee;
Woo Je Lee;
Joong-Yeol Park;
Ye-Jee Kim;
Chang Hee Jung;
Nauck, Michael A.

Publication type:

Article

Comparative evaluation of incretin-based antidiabetic medications and alternative therapies to be added to metformin in the case of monotherapy failure.

Published in:

Journal of Diabetes Investigation, 2010, v. 1, n. 1/2, p. 24, doi. 10.1111/j.2040-1124.2010.00004.x

By:

Nauck, Michael A;
Vardarli, Irfan

Publication type:

Article

Importance of localization of insulinomas: a systematic analysis.

Published in:

Journal of Hepato -- Biliary -- Pancreatic Sciences, 2019, v. 26, n. 9, p. 383, doi. 10.1002/jhbp.642

By:

Burghardt, Lilian;
Meier, Juris J.;
Uhl, Waldemar;
Kahle‐Stefan, Melanie;
Schmidt, Wolfgang E.;
Nauck, Michael A.

Publication type:

Article

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Published in:

2012

By:

Inzucchi, Silvio E.;
Bergenstal, Richard M.;
Buse, John B.;
Diamant, Michaela;
Ferrannini, Ele;
Nauck, Michael;
Peters, Anne L.;
Tsapas, Apostolos;
Wender, Richard;
Matthews, David R.

Publication type:

Journal Article

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Published in:

Diabetes Spectrum, 2012, v. 25, n. 3, p. 154, doi. 10.2337/diaspect.25.3.154

By:

Inzucchi, Silvio E.;
Bergenstal, Richard M.;
Buse, John B.;
Diamant, Michaela;
Ferrannini, Ele;
Nauck, Michael;
Peters, Anne L.;
Tsapas, Apostolos;
Wender, Richard;
Matthews, David R.

Publication type:

Article

Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.

Published in:

Critical Care, 2015, v. 19, n. 1, p. 1, doi. 10.1186/s13054-014-0718-3

By:

Kar, Palash;
Cousins, Caroline E.;
Annink, Christopher E.;
Jones, Karen L.;
Chapman, Marianne J.;
Meier, Juris J.;
Nauck, Michael A.;
Horowitz, Michael;
Deane, Adam M.

Publication type:

Article

Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.

Published in:

Critical Care, 2015, v. 19, n. 1, p. 15, doi. 10.1186/s13054-014-0718-3

By:

Kar, Palash;
Cousins, Caroline E.;
Annink, Christopher E.;
Jones, Karen L.;
Chapman, Marianne J.;
Meier, Juris J.;
Nauck, Michael;
Horowitz, Michael;
Deane, Adam M.

Publication type:

Article

Incretins and the development of type 2 diabetes.

Published in:

Current Diabetes Reports, 2006, v. 6, n. 3, p. 194, doi. 10.1007/s11892-006-0034-7

By:

Meier, Juris;
Nauck, Michael

Publication type:

Article

A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes.

Published in:

Diabetes Care, 2024, v. 47, n. 2, p. 184, doi. 10.2337/dc23-0925

By:

Karagiannis, Thomas;
Tsapas, Apostolos;
Bekiari, Eleni;
Toulis, Konstantinos A.;
Nauck, Michael A.

Publication type:

Article

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes.

Published in:

2021

By:

Riddle, Matthew C.;
Cefalu, William T.;
Evans, Philip H.;
Gerstein, Hertzel C.;
Nauck, Michael A.;
Oh, William K.;
Rothberg, Amy E.;
le Roux, Carei W.;
Rubino, Francesco;
Schauer, Philip;
Taylor, Roy;
Twenefour, Douglas;
le Roux, Carel W

Publication type:

journal article

Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes.

Published in:

2021

By:

Aigner, Lea;
Becker, Björn;
Gerken, Sonja;
Quast, Daniel R.;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

journal article

Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards.

Published in:

Diabetes Care, 2020, v. 43, n. 12, p. 2906, doi. 10.2337/dci20-0062

By:

Nauck, Michael A.;
Meier, Juris J.

Publication type:

Article

Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes.

Published in:

2020

By:

Quast, Daniel R.;
Schenker, Nina;
Menge, Björn A.;
Nauck, Michael A.;
Kapitza, Christoph;
Meier, Juris J.

Publication type:

journal article

Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis.

Published in:

2020

By:

Huthmacher, Jessica A.;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

journal article

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial.

Published in:

2020

By:

Buse, John B.;
Bain, Stephen C.;
Mann, Johannes F.E.;
Nauck, Michael A.;
Nissen, Steven E.;
Pocock, Stuart;
Poulter, Neil R.;
Pratley, Richard E.;
Linder, Martin;
Monk Fries, Tea;
Ørsted, David D.;
Zinman, Bernard;
LEADER Trial Investigators

Publication type:

journal article

Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920.

Published in:

2020

By:

Nauck, Michael A.;
Kreiner, Eskil;
Rasmussen, Søren;
Saevereid, Hans A.;
Buse, John B.;
LEADER Trial Investigators

Publication type:

Letter

Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial.

Published in:

2019

By:

Nauck, Michael A.;
Muus Ghorbani, Marie Louise;
Kreiner, Eskil;
Saevereid, Hans A.;
Buse, John B.;
LEADER Publication Committee on behalf of the LEADER Trial Investigators

Publication type:

journal article